DRUG: Belagenpumatucel-L
Help
Entry
D06563 Drug
Name
Belagenpumatucel-L (USAN);
Lucanix (TN)
Efficacy
Antineoplastic
Type
Cellular therapy product
Comment
Allogeneic vaccine cocktail of TGF-beta blocked, whole non-small cell lung cancer tumor cells.
Cell therapy treatment of non-small cell lung cancer
Target
TGFB2 [HSA:
7042
] [KO:
K13376
]
Pathway
hsa04060
Cytokine-cytokine receptor interaction
hsa04350
TGF-beta signaling pathway
hsa05200
Pathways in cancer
Brite
Target-based classification of drugs [BR:
br08310
]
Cytokines and receptors
Cytokines
Transforming growth factors (RSTK-binding)
TGFB2
D06563 Belagenpumatucel-L (USAN)
BRITE hierarchy
Other DBs
PubChem:
47208219
LinkDB
All DBs
» Japanese version
» Back
DBGET
integrated database retrieval system